Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital

References

• Lai X, Wang M, Qin C, et al. Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Netw Open. 2020;3(5):e209666.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242.
   PubMed Web of Science ®Google Scholar
• Khalil A, Hill R, Ladhani S, et al. COVID-19 screening of health-care workers in a London maternity hospital. Lancet Infect Dis. 2020;21:23–24.
   PubMed Web of Science ®Google Scholar
• Houlihan CF, Vora N, Byrne T, et al. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. The Lancet. 2020;396(10246):e6–e7.
   PubMed Web of Science ®Google Scholar
• Agren D. Understanding Mexican health worker COVID-19 deaths. The Lancet. 2020;396(10254):807.
   PubMed Web of Science ®Google Scholar
• Trieu MC, Bansal A, Madsen A, et al. SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. J Infect Dis. 2020. DOI:10.1093/infdis/jiaa737
   PubMedGoogle Scholar
• Galanis P, Vraka I, Fragkou D, et al. Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and meta-analysis. J Hosp Infect. 2020;108:120–134.
   PubMedGoogle Scholar
• Folkehelseinstituttet (The Norwegian Institute of Public Health). Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in April/May 2020 and August 2019. [cited 2020 Jul 31]. Available from: https://www.fhi.no/en/publ/2020/seroprevalence-of-sars-cov-2-in-the-norwegian-population–measured-in-resid/.
   Google Scholar
• Roche Diagnostics. Elecsys® Anti-SARS-CoV-2 immunoassay. 2019. [cited 2020 Jul 19]. Available from: https://diagnostics.roche.com/global/en/products/params/elecsys-anti-sars-cov-2.html
   Google Scholar
• DiaSorin. LIAISON® SARS-CoV-2 S1/S2 IgG. 2019. [cited 2020 Jul 19]. Available from: https://www.diasorin.com/sites/default/files/allegati/liaisonr_sars-cov-2_s1s2_igg_brochure.pdf.pdf
   Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
   PubMedGoogle Scholar
• Folgueira MD, Munoz-Ruiperez C, Alonso-Lopez MA, et al. SARS-CoV-2 infection in health care workers in a large public hospital in Madrid, Spain, during March 2020. medRxiv. 2020.
   Google Scholar
• Sikkema RS, Pas SD, Nieuwenhuijse DF, et al. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study. Lancet Infect Dis. 2020;20(11):1273–1280.
   PubMed Web of Science ®Google Scholar
• Liu M, Cheng SZ, Xu KW, et al. Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study. BMJ. 2020;369:m2195.
   PubMed Web of Science ®Google Scholar
• Ward H, Atchison CJ, Whitaker M, et al. Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. [cited 2020 Nov 4]. Available from: https://www.medrxiv.org/content/medrxiv/early/2020/08/21/2020.08.12.20173690.full.pdf
   Google Scholar
• Nguyen LH, Drew DA, Graham MS, et al.; Coronavirus Pandemic Epidemiology Consortium. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020;5(9):e475–e83.
   PubMed Web of Science ®Google Scholar
• Rudberg AS, Havervall S, Manberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064.
   PubMed Web of Science ®Google Scholar
• Rashid-Abdi M, Krifors A, Salleber A, et al. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study. Infect Dis (Lond). 2020;53(3):169–175.
   PubMed Web of Science ®Google Scholar
• Iversen K, Bundgaard H, Hasselbalch RB, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020;20(12):1401–1408.
   PubMed Web of Science ®Google Scholar
• Durante-Mangoni E, Andini R, Bertolino L, et al. Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting. Clin Microbiol Infect. 2020;26(9):1269–1270.
   PubMed Web of Science ®Google Scholar
• Ng K, Poon BH, Kiat Puar TH, et al. COVID-19 and the risk to health care workers: a case report. Ann Intern Med. 2020;172(11):766–767.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou M, Liu F. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. J Hosp Infect. 2020;105(1):100–101.
   PubMed Web of Science ®Google Scholar
• Chou R, Dana T, Buckley DI, et al. Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review. Ann Intern Med. 2020;173(2):120–136.
   PubMed Web of Science ®Google Scholar
• Ran L, Chen X, Wang Y, et al. Risk factors of healthcare workers with corona virus disease 2019: a retrospective cohort study in a designated hospital of Wuhan in China. Clin Infect Dis. 2020;71(16):2218–2221.
   PubMed Web of Science ®Google Scholar
• McMichael TM, Currie DW, Clark S, et al.; Public Health–Seattle and King County, EvergreenHealth, and CDC COVID-19 Investigation Team. Epidemiology of Covid-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020;382(21):2005–2011.
   PubMed Web of Science ®Google Scholar
• Arons MM, Hatfield KM, Reddy SC, et al.; Public Health–Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382(22):2081–2090.
   PubMed Web of Science ®Google Scholar
• Meredith LW, Hamilton WL, Warne B, et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. Lancet Infect Dis. 2020;20(11):1263–1272.
   PubMed Web of Science ®Google Scholar
• Meyerowitz EA, Richterman A, Bogoch II, et al. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2. Lancet Infect Dis. 2020.
   PubMedGoogle Scholar
• He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–675.
   PubMed Web of Science ®Google Scholar
• Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465–469.
   PubMed Web of Science ®Google Scholar
• Cereda D, Tirani M, Rovida F, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy. Submitted on 20th March 2020. [cited 2020 Nov 1]. Available from: arXiv.org/abs/2003.09320v1 .
   Google Scholar
• Lavezzo E, Franchin E, Ciavarella C, et al.; Imperial College COVID-19 Response Team. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 2020;584(7821):425–429.
   PubMed Web of Science ®Google Scholar
• Byambasuren O, Cardona M, Bell K, et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. J Assoc Med Microbiol Infect Dis Canada. 2020;5(4):223–234.
   Google Scholar
• He D, Zhao S, Lin Q, et al. The relative transmissibility of asymptomatic COVID-19 infections among close contacts. Int J Infect Dis. 2020; 94:145–147.
   PubMed Web of Science ®Google Scholar
• Koh WC, Naing L, Chaw L, et al. What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS One. 2020;15(10):e0240205.
   PubMed Web of Science ®Google Scholar
• Qiu X, Nergiz AI, Maraolo AE, et al. Defining the role of asymptomatic and pre-symptomatic SARS-CoV-2 transmission – a living systematic review. Clin Microbiol Infect. 2021. DOI:10.1101/2020.09.01.20135194
   PubMedGoogle Scholar
• Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200–1204.
   PubMed Web of Science ®Google Scholar